Skip to content

Correlation between peripheral blood neutrophil extracellular trapping level and blood stasis and toxin syndrome in patients with coronary heart disease

Correlation between peripheral blood neutrophil extracellular trapping level and blood stasis and toxin syndrome in patients with coronary heart disease

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300070893
Enrollment
Unknown
Registered
2023-04-25
Start date
2023-04-20
Completion date
Unknown
Last updated
2023-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary heart disease

Interventions

Sponsors

Xiyuan Hospital of China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Diagnosis meets the diagnostic criteria of stable coronary heart disease or acute coronary syndrome; 2. TCM diagnosis meets the diagnostic criteria of coronary heart disease syndrome of blood stasis; 3. Those aged 18-75 years old; 4. The people who signed the informed consent;

Exclusion criteria

Exclusion criteria: 1. Serious organic heart disease, such as LVEF&35% or NYHA/Killip grade IV patients; 2. Uncontrolled hypertension after medication (systolic blood pressure > 180mmHg, or diastolic blood pressure >110mmHg); 3. History of malignant arrhythmias (hemodynamic arrhythmias requiring drug or electric cardioversion, or cardiopulmonary resuscitation) and congenital heart disease in the last 1 year; 4. Acute cerebral apoplexy in the last 6 months; 5. People who have had major operations on the head, chest and abdomen in the past 1 month and have bleeding tendency; 6. Patients with systemic lupus erythematosus, organ transplantation history and other immune system diseases, malignant tumors or blood system diseases; 7. Severe liver and renal insufficiency: alanine aminotransferase (ALT) or aspartate aminotransferase (AST) >=1.5× upper limit of normal value (ULN); Or creatinine clearance (Ccr<30ml/min); 8. Co-infection (including but not limited to bacterial endocarditis, pulmonary infection, sepsis, etc.) or the use of antibiotics; 9. Participants in other clinical trials within 1 month

Design outcomes

Primary

MeasureTime frame
Neutrophil Extracellular Traps;Plasma NETs cfDNA levels;

Secondary

MeasureTime frame
Troponin T;Creatine kinase isoenzyme;Seattle Angina Scale (SAQ) score;Highly sensitive C-reactive protein;Coagulation function;Interleukin-6, IL-6;TNF-a;serum lipid level;fast blood glucose;N-terminal b-type natriuretic peptide precursor;Liver function;Kidney function;Blood stasis and toxin score;

Countries

China

Contacts

Public ContactZhuye Gao

Xiyuan Hospital of China Academy of Chinese Medical Sciences

zhuyegao@126.com+86 13146201102

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026